Metropolitan Life Insurance Company (MetLife)’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
HA
NMC
PAI
BC
AG
PIM
Metropolitan Life Insurance Company (MetLife)'s GOSS Position: Q1 2023 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 3,952 shares — an estimated $8.58K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $239K in Q3 2019. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,952 Gossamer Bio shares in Q1 2023, an estimated $8.58K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Gossamer Bio position peaked at $239K in Q3 2019.
- 111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.